Data / Federal rules / 2026-08178

Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal

The Drug Enforcement Administration published this proposed rule in the Federal Register on April 28, 2026.

SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.

Get new rules for your industry

What the agency says

The Department of Justice published a notice of proposed rulemaking in the Federal Register on May 21, 2024, which proposed to transfer marijuana from schedule I of the Controlled Substances Act to schedule III. The Drug Enforcement Administration ("DEA") published a notice of hearing on the proposed rule in the Federal Register on August 29, 2024. Upon further review, DEA is withdrawing the notice of hearing and terminating the pending hearing proceedings. As directed by Executive Order 14370, DEA has determined that the most expeditious manner of completing the rulemaking process in accordance with Federal law is to terminate the pending hearing proceedings and initiate new hearing proceedings. DEA is publishing a new notice of hearing elsewhere in this issue of the Federal Register.

Key facts

Document number: 2026-08178
Type: Proposed rule
Action: Notice of hearing on proposed rulemaking; withdrawal
Agency: Justice Department; Drug Enforcement Administration
Published: April 28, 2026
Dates: As of April 28, 2026, the notice of hearing on the proposed rule that was published in the Federal Register on August 29, 2024 (89 FR 70148), is withdrawn, and all hearing proceedings related thereto are terminated.
Docket: Docket No. DEA-1362; Attorney General Order No. 6752-2026
Code of Federal Regulations: 21 CFR 1301
Pages: 2

The document on federalregister.gov PDF

Other documents from the Drug Enforcement Administration

Document	Type	Published
Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I 2026-20943	Proposed rule	Oct 14
Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I 2026-20942	Proposed rule	Oct 14
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products 2026-20757	Final rule	Oct 9
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction 2026-20748	Final rule	Oct 9
Extension of Reexportation Period. 2026-20084	Proposed rule	Oct 1
Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I 2026-19400	Proposed rule	Sep 23
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I 2026-19231	Final rule	Sep 21
Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV 2026-17536	Final rule	Aug 27

Everything from the Drug Enforcement Administration · Published in April 2026

Read from the Federal Register API, last updated 2026-10-24. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.